These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24380864)

  • 41. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE; Wersinger C; Tomita Y; Sidhu A
    Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unique copper-induced oligomers mediate alpha-synuclein toxicity.
    Wright JA; Wang X; Brown DR
    FASEB J; 2009 Aug; 23(8):2384-93. PubMed ID: 19325037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
    Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
    Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons.
    Chavarría C; Rodríguez-Bottero S; Quijano C; Cassina P; Souza JM
    Biochem J; 2018 Oct; 475(19):3153-3169. PubMed ID: 30185433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
    Choong CJ; Say YH
    Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals.
    Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM
    Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores.
    Hu R; Diao J; Li J; Tang Z; Li X; Leitz J; Long J; Liu J; Yu D; Zhao Q
    Sci Rep; 2016 Feb; 6():20776. PubMed ID: 26865505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
    Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D
    FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein.
    Zhou ZD; Yap BP; Gung AY; Leong SM; Ang ST; Lim TM
    Exp Cell Res; 2006 Jan; 312(2):156-70. PubMed ID: 16297908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein.
    Carmo-Gonçalves P; do Nascimento LA; Cortines JR; Eliezer D; Romão L; Follmer C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):295-301. PubMed ID: 30249394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-Time Characterization of Cell Membrane Disruption by α-Synuclein Oligomers in Live SH-SY5Y Neuroblastoma Cells.
    Parres-Gold J; Chieng A; Wong Su S; Wang Y
    ACS Chem Neurosci; 2020 Sep; 11(17):2528-2534. PubMed ID: 32786327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine prevents lipid peroxidation-induced accumulation of toxic α-synuclein oligomers by preserving autophagy-lysosomal function.
    Jiang P; Gan M; Yen SH
    Front Cell Neurosci; 2013; 7():81. PubMed ID: 23754979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking.
    Choi BK; Choi MG; Kim JY; Yang Y; Lai Y; Kweon DH; Lee NK; Shin YK
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):4087-92. PubMed ID: 23431141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States.
    Illes-Toth E; Dalton CF; Smith DP
    J Am Soc Mass Spectrom; 2013 Sep; 24(9):1346-54. PubMed ID: 23817832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maysin plays a protective role against α-Synuclein oligomers cytotoxicity by triggering autophagy activation.
    Leri M; Vasarri M; Palazzi L; Barletta E; Nielsen E; Bucciantini M; Degl'Innocenti D
    Food Chem Toxicol; 2020 Oct; 144():111626. PubMed ID: 32738375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha-synuclein oligomerization increases its effect on promoting NMDA receptor internalization.
    Yu W; Yang W; Li X; Li X; Yu S
    Int J Clin Exp Pathol; 2019; 12(1):87-100. PubMed ID: 31933723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The early events of alpha-synuclein oligomerization revealed by photo-induced cross-linking.
    Li HT; Lin XJ; Xie YY; Hu HY
    Protein Pept Lett; 2006; 13(4):385-90. PubMed ID: 16712515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitors of α-Synuclein Fibrillation and Oligomer Toxicity in
    Eskandari H; Ghanadian M; Noleto-Dias C; Lomax C; Tawfike A; Christiansen G; Sutherland DS; Ward JL; Mohammad-Beigi H; Otzen DE
    ACS Chem Neurosci; 2020 Oct; 11(19):3161-3173. PubMed ID: 32886481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elucidating the aggregation number of dopamine-induced α-synuclein oligomeric assemblies.
    Zijlstra N; Claessens MM; Blum C; Subramaniam V
    Biophys J; 2014 Jan; 106(2):440-6. PubMed ID: 24461019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.